Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

NETWORK 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 55Other hematologic neoplasm 11Plasma cell 10Lymphoid 10Breast 6Other neoplasm 5Thoracic 3Myeloid 3Dermatologic 3Gynecologic 2Genitourinary 2Gastrointestinal 2Head & Neck 1

Conditions

Anemia 2Uterine Cervical Neoplasms 1Small Cell Lung Carcinoma 1Radiation Injuries 1Prostatic Neoplasms 1Ovarian Neoplasms 1Neoplasms 1Multiple Myeloma 1Lymphoma 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1Breast Neoplasms 1

Interventions

Epoetin Alfa 2Darbepoetin alfa 2Cisplatin 2Brachytherapy 2stinging nettle lectin 1peppermint oil 1niraparib 1ferrous fumarate 1epoetin beta 1angiotensin I (1-7) 1Therapeutics 1Radiotherapy 1Paclitaxel 1Ferric Oxide, Saccharated 1Erythropoietin 1Carboplatin 1Blood Transfusion 1ACE-011 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anemia × Epoetin Alfa × Gynecologic × Clear all
NCT00017004 2017-08-09

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

GOG Foundation

Phase 3 Completed
114 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

NCT00270166 2011-05-18

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Phase 3 Completed
201 enrolled
BreastClassical hematologyGastrointestinalGenitourinaryGynecologicLymphoidPlasma cellThoracic

Anemia, Breast Neoplasms, Esophageal Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡